FDA Clearance Tracker · P160036-S004
Hintermann Series H3 Total Ankle Replacement System
Last checked: Nov 20, 2026Latest source record: Nov 6, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Nov 6, 2023
Approved
Time to decision
182 days
Received May 8, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P160036-S004
- Device name
- Hintermann Series H3 Total Ankle Replacement System
- Applicant
- Dt Medtech, LLC
- Applicant location
- Towson, MD
- Received
- May 8, 2023
- Decided
- Nov 6, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P160036
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval to introduce patient specific instrumentation (i.e., OPTIX Patient Specific Instruments (PSI)) to the Hintermann Series H3 Total Ankle Replacement System.
Source documents
Other decisions for Dt Medtech, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P160036 · Decided Jun 4, 2019 · 1,014 days after receipt
Device type: Prosthesis, ankle, uncemented, non-constrained (NTG) · Orthopedic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.